Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function

Canadian Journal of Cardiology

Volumn 13, Issue 5, 1997, Pages 479-485

  Marcotte, François ^a   Honos, George N ^a   Walling, Ann D ^a   Beauvais, Desneiges ^a   Blais, Marie Josée ^a   Daoust, Carole ^a   Lisbona, André ^a   McCans, John L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Angiotensin converting enzyme inhibitor; Doppler echocardiography; Mitral regurgitation

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDEMA; FATIGUE; FEMALE; HEADACHE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MITRAL VALVE REGURGITATION; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; VERTIGO;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; VENTRICULAR FUNCTION, LEFT;

EID: 0030992906     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Enriquez-Sarano M, Tajik AJ, Bailey KR, Seward JB. Color flow imaging compared with quantitative Doppler assessment of severity of mitral regurgitation: influence of eccentricity of jet and mechanism of regurgitation. J Am Coll Cardiol 1993;21:1211-9.
2. Rappaport E. Natural history of aortic and mitral valve disease. Am J Cardiol 1975;35:221-7.
3. Hammermeister KE, Fisher L, Kennedy JW, et al. Prediction of late survival in patients with mitral valve disease from clinical, hemodynamic, and quantitative angiographic variables. Circulation 1978;57:341-9.
4. Rosen S, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994;74:374-80.
5. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
6. Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:654-8.
7. Weiland DS, Konstam MA, Salem DN, et al. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:1046-50.
8. Evangelista-Massip A, Bruguera-Cortada J, Serrat-Serradell R, et al. Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:373-6.
9. Greenberg BH, Massie BM, Brundage BH, et al. Beneficial effects of hydralazine in severe mitral regurgitation. Circulation 1978;58:273-8.
10. Greenberg BH, DeMots H, Murphy E, Rahimtoola SH. Arterial vasodilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term follow-up. Circulation 1982;65:181-7.
11. Blackford LW, Golden AL, Bright JM, et al. Captopril provides sustained hemodynamic benefits in dogs with experimentally induced mitral regurgitation. Vet Surg 1990;19:237-2.
12. Wisenbaugh T, Sinovich V, Dullabh A, et al. Six month pilot study of captopril for symptomatic severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994;3:197-204.
13. Schön HR Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation J Hypertens 1994;12(Suppl 4):S95-104.
14. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes Circulation 1987;75:175-83.
15. Spain MG, Smith MD, Grayburn PA, et al. Quantitative assessment of mitral regurgitation by Dopplet color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 1989;13:585-90.
16. Devereux RB, Alonso DR, Lutas EM. Echocardiographic assessment of left ventricular hypertrophy: comparison with necropsy findings. Am J Cardiol 1986;57:450-8.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman AE. The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-Mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-82
18. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Hypertension 1987;9:II19-26.
19. Starling MR, Crawford MH, Sorensen SG, et al. Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium angiography for estimating left ventricular size and performance. Circulation 1981;63:1075-84.
20. Vandenbossche J-L, Kramer BL, Massie BM, et al. Two-dimensional echocardiographic evaluation of the left ventricle in chronic aortic regurgitation: comparison with radionuclide angiography. J Am Coll Cardiol 1984;4:1196-206.
21. Rokey R, Sterling LL, Zoghbi WA, et al. Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol 1986;7:1273-8.
22. Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo E. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992;19:74-81.
23. Henry WL, DeMaria A, Feigenbaum H, et al. Report of The American Society of Echocardiography Committee on Nomenclature and Standards: Identification of Myocardial Wall Segments. Raleigh: The American Society of Echocardiography, 1982.
24. Testa MA. Interpreting quality of life data for use in the clinical practice of antihypertensive therapy. J Hypertens 1987;(Suppl 5): S9-13.
25. Larrey D, Babany J, Andrieux J, et al. Fulminant hepatitis after lisinopril administration. Gastroenterology 1990,89:1832-3.
26. Burwash IG, Blackmore GL, Koipilai CJ. Usefulness of left atrial and left ventricular chamber sizes as predictors of the severity of mitral regurgitation. Am J Cardiol 1992;70:774-9.
27. Otsuji Y, Tei C, Kisanuki A, et al. Color Doppler echocardiographic assessment of the change in the mitral regurgitant volume. Am Heart J 1987:114:349-54.
28. Graybum PA, Pryor SL, Levine BD, et al. Day to day variability of Doppler color flow jets in mitral regurgitation. J Am Coll Cardiol 1989;14:936-40.
29. Lin LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417.